Houlihan Financial Resource Group, Ltd. Gritstone Bio, Inc. Transaction History
Houlihan Financial Resource Group, Ltd.
- $235 Million
- Q4 2024
A detailed history of Houlihan Financial Resource Group, Ltd. transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Houlihan Financial Resource Group, Ltd. holds 12,000 shares of GRTS stock, worth $360. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,000
Previous 20,000
40.0%
Holding current value
$360
Previous $12,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GRTS
# of Institutions
12Shares Held
1.2MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY872KShares$26,1590.0% of portfolio
-
Telemetry Investments, L.L.C. New York, NY105KShares$3,1500.57% of portfolio
-
Baader Bank Aktiengesellschaft Unterschleissheim, 2M67.1KShares$2,0140.0% of portfolio
-
Act Capital Management, LLC Wayne, PA47.5KShares$1,4250.17% of portfolio
-
Simplex Trading, LLC44.2KShares$1,3260.0% of portfolio
About Gritstone bio, Inc.
- Ticker GRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,006,896
- Market Cap $2.19M
- Description
- Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...